Genomic Medicine Market, By Type (Predictive Genomic Medicine, Preventive Genomic Medicine, Diagnostic Genomic Medicine, and Therapeutic Genomic Medicine), By Application, By Technology, By Component, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV4851
|
Published Date
March 2026
|
Pages
328
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Genomic Medicine Market size was valued at US$ 35,984.98 Million in 2025, expanding at a CAGR of 16.35% from 2026 to 2033.
Genomic medicine is an advanced healthcare approach that leverages an individual’s genetic information (DNA) to enhance disease prevention, diagnosis, and treatment. Because each person’s genetic profile is unique, analyzing genetic variations allows healthcare professionals to understand why certain individuals are more susceptible to specific diseases or respond differently to therapies. By interpreting this genetic data, clinicians can identify disease risks early, tailor treatments to the patient, and optimize therapeutic outcomes. This personalized approach is particularly impactful in areas such as cancer therapy, rare disease diagnosis, and precision drug selection.
Globally, the adoption of genomic medicine is accelerating as governments implement national genome initiatives to improve healthcare quality and patient outcomes. For example, the UK’s Genomics England program successfully completed the 100,000 Genomes Project, sequencing over 100,000 genomes from approximately 85,000 patients with rare diseases and cancers. Such government-backed programs are enhancing genomic research infrastructure, supporting clinical adoption of genomic technologies, and driving the integration of precision medicine into mainstream healthcare systems worldwide.
Genomic Medicine Market- Market Dynamics
Rising Adoption of Precision Medicine to Drive Market Growth
The growing integration of precision medicine is significantly fueling the expansion of the genomic medicine market. Precision medicine focuses on tailoring healthcare strategies based on an individual’s genetic profile, lifestyle, and environmental factors. Advances in genomic sequencing, molecular diagnostics, and bioinformatics allow clinicians to better understand disease mechanisms, identify relevant biomarkers, and select therapies that are specifically suited to each patient. As healthcare providers increasingly adopt personalized treatment approaches, the demand for genomic testing, analysis, and interpretation continues to rise.
Government-led initiatives are playing a key role in accelerating this shift toward individualized care. For example, the UK Department of Health and Social Care, through the NHS England Genomic Medicine Service, conducted over 800,000 genomic tests in 2023 to aid in diagnosing rare genetic disorders and various cancers, demonstrating a strong commitment to precision-based healthcare delivery. Alongside government programs, biotechnology firms are expanding genomic capabilities to support clinical adoption of personalized medicine. BGI Genomics, for instance, has processed tens of millions of sequencing tests worldwide across clinical diagnostics, reproductive health, and disease research. Such large-scale genomic testing facilitates the identification of genetic variations and actionable biomarkers, enabling healthcare providers to implement targeted therapies and reinforce the broader adoption of precision medicine globally.
Genomic Medicine Market- Segmentation Analysis:
The Global Genomic Medicine Market is segmented on the basis of Type, Application, Technology, Component, End User, and Region.
Based on type, Diagnostic Genomic Medicine is expected to remain a dominant segment within the genomic medicine market due to its essential role in identifying genetic variations linked to a wide range of diseases. The widespread adoption of genomic sequencing and molecular diagnostic technologies has enabled clinicians to detect rare diseases, genetic disorders, and cancers at earlier stages. These diagnostic tools support more precise clinical decision-making by facilitating personalized treatment strategies. For example, the NHS England Genomic Medicine Service conducted over 810,000 genomic tests in 2024, covering more than 7,000 rare diseases and over 200 cancer indications. This growing clinical utilization underscores the critical role of diagnostic genomic medicine in advancing early detection and precision healthcare on a global scale.
In terms of components, the market is segmented into Instruments, Consumables, and Software & Services. Among these, Consumables are expected to hold a substantial share due to their recurring usage in sequencing and genomic testing workflows. Consumables such as reagents, sequencing kits, and flow cells are essential for every genomic experiment and diagnostic test, creating consistent demand across clinical laboratories and research institutions. For instance, Illumina reported approximately $3.9 billion in revenue from sequencing consumables in 2023, highlighting the extensive reliance on these products for genomic research and clinical diagnostics. This recurring utilization emphasizes the pivotal role of consumables in supporting large-scale genomic testing and enabling precision medicine initiatives worldwide.
Genomic Medicine Market- Geographical Insights
The global genomic medicine market is steadily expanding across multiple regions, driven by advancements in healthcare infrastructure, increasing genomic research initiatives, and supportive government policies that promote precision medicine. North America maintains a prominent position, thanks to its robust institutional framework and substantial investment in genomic innovation. Government agencies and research institutions actively facilitate genomic sequencing, data integration, and the development of personalized treatment approaches. For instance, the National Institutes of Health (NIH) launched the All of Us Research Program, which aims to collect health and genetic data from over one million participants to advance precision medicine research and improve individualized healthcare strategies.
Within North America, the United States plays a leading role in driving genomic medicine through both public and private sector initiatives. National precision medicine programs have already generated genomic datasets from hundreds of thousands of participants, supporting disease research and therapeutic development. At the same time, biotechnology companies such as Illumina and Thermo Fisher Scientific are expanding genomic sequencing technologies and molecular diagnostic solutions. Illumina, for example, reports that its sequencing platforms have produced a majority of the world’s genomic data, supporting hospitals, research laboratories, and national genome projects globally. Together, these government programs and industry innovations reinforce the U.S.’s leadership in genomic medicine and solidify North America’s influence in the worldwide market.
Japan Genomic Medicine Market- Country Insights
In Japan, the genomic medicine market is experiencing steady growth, driven by strong government support for precision healthcare and genomic research. The Ministry of Health, Labour and Welfare has championed nationwide genomic programs aimed at incorporating genetic information into routine clinical care, particularly for cancer diagnosis and treatment. Simultaneously, the Japan Agency for Medical Research and Development (AMED) funds large-scale genome research projects to advance disease prevention and enable personalized therapies, further strengthening the country’s genomic medicine ecosystem.
Japan has also launched targeted initiatives such as the Initiative on Rare and Undiagnosed Diseases (IRUD), supported by AMED, to improve the diagnosis and management of rare genetic disorders. Government reports indicate that the program has analyzed genomic data from tens of thousands of patients, aiding both clinical diagnosis and research. Additionally, national policies promoting genomic data sharing, coupled with investments in advanced medical research infrastructure, are expected to accelerate the adoption of genomic medicine and foster innovation across Japan’s healthcare system.
Genomic Medicine Market- Competitive Landscape:
The global genomic medicine market is highly competitive, driven by continuous advancements in genomic technologies and the growing adoption of precision medicine. The industry comprises both established international biotechnology leaders and emerging genomic solution providers, offering a wide range of sequencing platforms, diagnostic tools, and genomic services. Companies distribute their products through direct sales, collaborations with hospitals, research institutions, and pharmaceutical partners. Competition is primarily based on technological innovation, sequencing accuracy, data analytics capabilities, product reliability, and service availability. Leading players such as Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, QIAGEN, and Agilent Technologies are actively pursuing strategies including new product development, expansion of research infrastructure, strategic partnerships, and acquisitions to strengthen market presence and drive advances in genomics-based healthcare.
Recent Developments:
- In December 2025, Illumina entered a collaboration and strategic investment agreement with MyOme to advance genomic health modeling and large-scale clinical trials using whole-genome sequencing integrated with AI-driven risk models. This partnership aims to improve early disease detection and preventive healthcare strategies.
- In October 2025, Thermo Fisher Scientific formed a strategic co-marketing agreement with Genovation Health and XYGene to expand access to integrated genomic testing solutions. The collaboration combines microarray-based genomic data with clinical decision-support tools to accelerate applications in precision medicine and pharmacogenomics.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENOMIC MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- BGI Genomics
- Illumina
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
- QIAGEN
- Agilent Technologies
- BGI Genomics
- Pacific Biosciences
- Oxford Nanopore Technologies
- Bio-Rad Laboratories
- PerkinElmer
- Myriad Genetics
- Eurofins Scientific
- Guardant Health
- Natera
- 23andMe, Inc.
- Exact Sciences
- Others
GLOBAL GENOMIC MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Predictive Genomic Medicine
- Preventive Genomic Medicine
- Diagnostic Genomic Medicine
- Therapeutic Genomic Medicine
GLOBAL GENOMIC MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Rare Genetic Diseases
- Infectious Diseases
- Pharmacogenomics
- Others
GLOBAL GENOMIC MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Gene Editing Technologies
GLOBAL GENOMIC MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033
- Instruments
- Consumables
- Software & Services
- Others
GLOBAL GENOMIC MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Institutes
- Pharmaceutical & Biotechnology Companies
GLOBAL GENOMIC MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Genomic Medicine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Genomic Medicine Market Snippet by Type
2.1.2. Genomic Medicine Market Snippet by Application
2.1.3. Genomic Medicine Market Snippet by Technology
2.1.4. Genomic Medicine Market Snippet by Component
2.1.5. Genomic Medicine Market Snippet by End User
2.1.6. Genomic Medicine Market Snippet by Country
2.1.7. Genomic Medicine Market Snippet by Region
2.2. Competitive Insights
3. Genomic Medicine Key Market Trends
3.1. Genomic Medicine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Genomic Medicine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Genomic Medicine Market Opportunities
3.4. Genomic Medicine Market Future Trends
4. Genomic Medicine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Genomic Medicine Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Genomic Medicine Market Landscape
6.1. Genomic Medicine Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Genomic Medicine Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Predictive Genomic Medicine
7.1.3. Preventive Genomic Medicine
7.1.4. Diagnostic Genomic Medicine
7.1.5. Therapeutic Genomic Medicine
8. Genomic Medicine Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Oncology
8.1.3. Rare Genetic Diseases
8.1.4. Infectious Diseases
8.1.5. Pharmacogenomics
8.1.6. Others
9. Genomic Medicine Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
9.1.2. Next-Generation Sequencing (NGS)
9.1.3. Polymerase Chain Reaction (PCR)
9.1.4. Microarray
9.1.5. Gene Editing Technologies
10. Genomic Medicine Market – By Component
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
10.1.2. Instruments
10.1.3. Consumables
10.1.4. Software & Services
10.1.5. Others
11. Genomic Medicine Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Hospitals & Clinics
11.1.3. Diagnostic Laboratories
11.1.4. Research Institutes
11.1.5. Pharmaceutical & Biotechnology Companies
12. Genomic Medicine Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Genomic Medicine Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Genomic Medicine Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Genomic Medicine Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Genomic Medicine Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Genomic Medicine Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Genomic Medicine Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. BGI Genomics
13.2.2. Illumina
13.2.3. Thermo Fisher Scientific
13.2.4. F. Hoffmann-La Roche
13.2.5. QIAGEN
13.2.6. Agilent Technologies
13.2.7. BGI Genomics
13.2.8. Pacific Biosciences
13.2.9. Oxford Nanopore Technologies
13.2.10. Bio-Rad Laboratories
13.2.11. PerkinElmer
13.2.12. Myriad Genetics
13.2.13. Eurofins Scientific
13.2.14. Guardant Health
13.2.15. Natera
13.2.16. 23andMe, Inc.
13.2.17. Exact Sciences
13.2.18. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENOMIC MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- BGI Genomics
- Illumina
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
- QIAGEN
- Agilent Technologies
- BGI Genomics
- Pacific Biosciences
- Oxford Nanopore Technologies
- Bio-Rad Laboratories
- PerkinElmer
- Myriad Genetics
- Eurofins Scientific
- Guardant Health
- Natera
- 23andMe, Inc.
- Exact Sciences
- Others
GLOBAL GENOMIC MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Predictive Genomic Medicine
- Preventive Genomic Medicine
- Diagnostic Genomic Medicine
- Therapeutic Genomic Medicine
GLOBAL GENOMIC MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Rare Genetic Diseases
- Infectious Diseases
- Pharmacogenomics
- Others
GLOBAL GENOMIC MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Gene Editing Technologies
GLOBAL GENOMIC MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033
- Instruments
- Consumables
- Software & Services
- Others
GLOBAL GENOMIC MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Institutes
- Pharmaceutical & Biotechnology Companies
GLOBAL GENOMIC MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
